• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

MAXCYTE INC

Notes

No. Proposition For Against Abstain
1

ELECTION OF CLASSI DIRECTOR - MAHER MASOUD

2

ELECTION OF CLASSI DIRECTOR - YASIR AL-WAKEEL

3

ELECTION OF CLASSI DIRECTOR - REKHA HEMRAJANI

4

TO APPROVE AN AMENDMENT TO THE MAXCYTE, INC. 2022 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF THE COMPANYS COMMON STOCK ISSUABLE THEREUNDER BY 2,950,000 SHARES

5

TO APPROVE THE CANCELLATION OF ADMISSION TO TRADING OF THE COMPANYS COMMON STOCK ON AIM, A SECURITIES TRADING MARKET OF THE LONDON STOCK EXCHANGE PLC IN THE UNITED KINGDOM

6

TO RATIFY THE AUDIT COMMITTEES SELECTION OF COHNREZNICK LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025

7

TO APPROVE THE ADJOURNMENT OF THE ANNUAL MEETING TO A LATER DATE OR DATES, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES